All companies › HTFL

HTFL · Heartflow, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells16
Research cases0
Last filing2026-10-22

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-17 — Rogers Campbell · sold 9,219 @ $41.23 2026-08-18 — Farquhar John C.M. · sold 32,676 @ $45.00 2026-08-21 — Farquhar John C.M. · sold 27,230 @ $50.00 2026-09-02 — Verghese Vikram · sold 5,876 @ $50.60 2026-09-03 — Verghese Vikram · sold 27,540 @ $49.69 2026-09-08 — Verghese Vikram · sold 6,640 @ $50.03 2026-09-10 — Farquhar John C.M. · sold 35,010 @ $46.42 2026-09-11 — Verghese Vikram · sold 29,714 @ $50.06 2026-09-11 — Farquhar John C.M. · sold 3,890 @ $50.00 2026-09-14 — Verghese Vikram · sold 4,593 @ $50.24 2026-09-15 — Verghese Vikram · sold 668 @ $50.01 2026-09-17 — Verghese Vikram · sold 7,579 @ $50.11 2026-09-18 — Rogers Campbell · sold 19,682 @ $50.15 2026-09-18 — Verghese Vikram · sold 16,766 @ $50.75 2026-10-12 — Farquhar John C.M. · sold 38,900 @ $49.57 2026-10-22 — Rogers Campbell · sold 23,933 @ $55.01
2026-08-172026-10-22

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Verghese Vikram Chief Financial Officer
Farquhar John C.M. Chief Executive Officer, Director
Rogers Campbell Chief Medical Officer
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $HTFL is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-10-22', 'insider_name': 'Rogers Campbell', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 23933.0, 'price': 55.01, 'value': 1316554.33, 'is_buy': False}, {'transaction_date': '2026-10-12', 'insider_name': 'Farquhar John C.M.', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 38900.0, 'price': 49.568, 'value': 1928195.2, 'is_buy': False}, {'transaction_date': '2026-09-18', 'insider_name': 'Rogers Campbell', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 19682.0, 'price': 50.15, 'value': 987052.3, 'is_buy': False}, {'transaction_date': '2026-09-18', 'insider_name': 'Verghese Vikram', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 16766.0, 'price': 50.7531, 'value': 850926.47, 'is_buy': False}, {'transaction_date': '2026-09-17', 'insider_name': 'Verghese Vikram', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 7579.0, 'price': 50.1142, 'value': 379815.52, 'is_buy': False}, {'transaction_date': '2026-09-15', 'insider_name': 'Verghese Vikram', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 668.0, 'price': 50.01, 'value': 33406.68, 'is_buy': False}, {'transaction_date': '2026-09-14', 'insider_name': 'Verghese Vikram', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 4593.0, 'price': 50.24, 'value': 230752.32, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'Verghese Vikram', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 29714.0, 'price': 50.06, 'value': 1487482.84, 'is_buy': False}, {'transaction_date': '2026-09-11', 'insider_name': 'Farquhar John C.M.', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 3890.0, 'price': 50.0, 'value': 194500.0, 'is_buy': False}, {'transaction_date': '2026-09-10', 'insider_name': 'Farquhar John C.M.', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 35010.0, 'price': 46.42, 'value': 1625164.2, 'is_buy': False}, {'transaction_date': '2026-09-08', 'insider_name': 'Verghese Vikram', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 6640.0, 'price': 50.03, 'value': 332199.2, 'is_buy': False}, {'transaction_date': '2026-09-03', 'insider_name': 'Verghese Vikram', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 27540.0, 'price': 49.69, 'value': 1368462.6, 'is_buy': False}, {'transaction_date': '2026-09-02', 'insider_name': 'Verghese Vikram', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 5876.0, 'price': 50.6, 'value': 297325.6, 'is_buy': False}, {'transaction_date': '2026-08-21', 'insider_name': 'Farquhar John C.M.', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 27230.0, 'price': 50.0, 'value': 1361500.0, 'is_buy': False}, {'transaction_date': '2026-08-18', 'insider_name': 'Farquhar John C.M.', 'insider_title': 'Chief Executive Officer, Director', 'transaction_type': 'Open-market sell', 'shares': 32676.0, 'price': 45.0, 'value': 1470420.0, 'is_buy': False}, {'transaction_date': '2026-08-17', 'insider_name': 'Rogers Campbell', 'insider_title': 'Chief Medical Officer', 'transaction_type': 'Open-market sell', 'shares': 9219.0, 'price': 41.23, 'value': 380099.37, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for HTFL today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.